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2 
MANUSCRIPT 
Theoretical scenario 
Clinical trials using categorical outcomes often express their results as risk, which is the probability with 
which a health outcome (usually an adverse event) will occur. For this article two scenarios on early 
treatment of either Class II or Class III malocclusion are discussed. 
In the first scenario three widely known randomized trials on early Class II (2-phase) treatment 
versus delayed (1-phase) treatment are summarized by a recently updated Cochrane review (Batista et al. 
2018). For this article, the results of two kinds of early treatment (headgear and functional appliances) 
have been combined into a single group. Setting other trial results aside, the authors followed patients 
from the start of early treatment (if administered) to the end of fixed appliance treatment and measured the 
incidence of new dental trauma. The effect of treatment on new trauma risk (=incidence) is here presented 
as Relative Risk (RR) with its 95% Confidence Interval (CI). The RR is the appropriate effect size to 
express a treatment-induced relative change of risk (Sinclair and Bracken 1994). 
In the second scenario a long-term randomized trial of early maxillary protraction for Class III 
treatment compared to no treatment (observation) is presented (Mandall et al. 2016). The authors followed 
patients from the start of early treatment (if administered) and assessed at 15 years of age their need for 
orthognathic surgery through a blinded panel of consultants. The effect of treatment on the need for 
orthognathic surgery is likewise presented as RR with its 95% CI. 
The RRs of treatment-induced effects on dental trauma and need for surgery are given in Table 1 
with the corresponding 95% CIs. 
 
Table 1 around here (on the first page). 
 
Which of the following statements are correct, if any: 
(a) The relative effect size of treatment is similar in the two scenarios. 
(b) The absolute effect size of treatment is similar in the two scenarios. 
(c) The risk for dental trauma and the need for surgery among treated Class II / Class III patients is 
similar. 
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(d) The absolute gains from early Class II or Class III treatment are the same for all patients that are 
treated early. 
 
Discussion 
The first statement refers to the magnitude of the relative effect size, which is here the RR. The two 
scenarios have similar RRs (both around 0.6) and with similar uncertainty around them (95% CIs of 0.4-
0.9 and 0.3-0.9). The p values are somewhat different, but this can be attributed to different sample sizes 
in the two scenarios and p values do not give information about the magnitude of an effect anyway. 
Overall, statement (a) is correct. 
 The second statement refers to the absolute effect size, which is different to the relative effect 
size. It is recommended that clinical trials report both relative and absolute effects to give a complete 
picture of the treatment effects and their implications (Moher et al. 2010). The recommended absolute 
effect size is the risk difference, which is simply the difference of the two groups’ risks. If risk differences 
are calculated, it is obvious that the absolute effect sizes for the two scenarios differ: -11.4% for the first 
scenario and -29.3% for the second scenario (Table 2) and therefore, statement (b) is false. 
 
Table 2 around here (on the second or third page). 
 
Even though the relative effects are similar, the absolute effects vary considerably. This has to do with the 
fact that the patient’s baseline (pre-treatment) risk has a direct effect on the absolute gains attained by 
treatment. This is illustrated in Figures 1 and 2. We see that the baseline risk for dental trauma among 
untreated Class II patients (in these trials) is 29.1%, while the baseline need for orthognathic surgery 
among untreated Class III patients (in this trial) is 65.6% (Figure 1 and Figure 2, respectively). 
Subsequently, early Class II treatment ‘saves’ 11 of every 100 patients from a dental trauma they would 
have had if left untreated, while early Class III treatment ‘saves’ 30 of every 100 patients from orthognathic 
surgery that would be needed if left untreated. In the end and with the same relative effects, the risks (for 
trauma/surgery) are reduced in both scenarios compared to untreated patients, but both the absolute risk 
reduction and the risk of treated patients is different between the two scenarios. So statement (c) is wrong. 
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 Finally, for a given relative effect the absolute risk reduction is directly linked to the patient’s 
baseline risk. In the first scenario about Class II early treatment, this pertains to a patient’s baseline risk 
for dental trauma. It is known however, that not trauma risk is not uniform across the general population 
and several factors are linked to increased trauma risks, including among others patient sex, obesity, 
inadequate lip coverage, increased overjet, and involvement into sport activities (Soriano et al. 2007; 
Glendor 2009). It is reasonable to assume that a normal-weight girl with moderate overjet and adequate 
lip coverage, who does ballet will have a lower risk for dental trauma than an obese boy with large overjet 
and inadequate lip coverage, who plays basketball. As can be seen in Figure 3, the expected absolute 
treatment gains for early Class II correction are different for the hypothetical low-risk girl and high-risk boy. 
Therefore, statement (d) is false, and the expected net gains of treatment rely on the patients one selects 
to treat. 
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6 
TABLES 
Table 1. Results of the two clinical scenarios. 
Scenario Outcome RR 95% CI P 
Early Class II Tx New dental trauma 0.61 0.42 to 0.87 0.006 
Early Class III Tx Need for orthognathic surgery 0.55 0.33 to 0.93 0.03 
CI, confidence interval; RR, relative risk; Tx, treatment. 
 
 
Table 2. Results of the two clinical scenarios including relative and absolute effects. 
Scenario Outcome 
Risk 
Control 
Risk 
Tx 
Effect 95% CI P 
Early Class II 
Tx 
New dental trauma 29.1% 17.7% RR=0.61 0.42 to 0.87 0.006 
    RD=-11.4% -21.4 to -1.3% 0.03 
       
Early Class III 
Tx 
Need for 
orthognathic surgery 
65.6% 36.3% RR=0.55 0.33 to 0.93 0.03 
    RD=-29.3% -52.5 to -6.0% 0.01 
CI, confidence interval; RD, relative difference; RR, relative risk; Tx, treatment. 
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Figure 1. Illustrative risks of dental trauma for the scenario of early Class II treatment.
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Figure 2. Illustrative risks of need for surgery for the scenario of early Class III treatment
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Figure 3. Illustrative gains in terms of dental trauma risk reduction for the scenario of early Class II 
treatment. Comparison between patients with baseline low risk of trauma and patients with high risk 
of trauma (assuming a modest high-risk/low-risk ratio of 3).
